Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus.

[1]  J. Ioannidis,et al.  Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. , 2000, QJM : monthly journal of the Association of Physicians.

[2]  J. Ioannidis,et al.  Risk factors for central nervous system involvement in systemic lupus erythematosus. , 2000, QJM : monthly journal of the Association of Physicians.

[3]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[4]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[5]  G. Hughes,et al.  Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. , 1995, The American journal of medicine.

[6]  I. Scharrer,et al.  Criteria for the Diagnosis of Lupus Anticoagulants: An Update , 1995, Thrombosis and Haemostasis.

[7]  D. Gladman.  Prognosis and treatment of systemic lupus erythematosus , 1995, Current opinion in rheumatology.

[8]  S. West,et al.  Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. , 1995, The American journal of medicine.

[9]  D. Borenstein,et al.  Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. , 1995, The American journal of medicine.

[10]  D. Gladman,et al.  Dilemmas in neuropsychiatric lupus. , 1993, Rheumatic diseases clinics of North America.

[11]  F. Quismorio,et al.  Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. , 1993, Seminars in arthritis and rheumatism.

[12]  Y. Sidi,et al.  Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. , 1992, The Journal of rheumatology.

[13]  J. Sibley,et al.  The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. , 1992, The Journal of rheumatology.

[14]  P. Turski,et al.  Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. , 1991, Arthritis and rheumatism.

[15]  J. Denburg,et al.  Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. The Ad Hoc Neuropsychiatric Lupus Workshop Group. , 1990, The Journal of rheumatology.

[16]  R. Griffey,et al.  Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.

[17]  A. Aisen,et al.  Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. , 1988, Arthritis and rheumatism.

[18]  A. Drosos,et al.  Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. , 1987, Clinical immunology and immunopathology.

[19]  H. Bluestein.  Neuropsychiatric manifestations of systemic lupus erythematosus. , 1987, The New England journal of medicine.

[20]  L A Saint-Louis,et al.  Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. , 1986, AJR. American journal of roentgenology.

[21]  A. Aisen,et al.  MR imaging of systemic lupus erythematosus involving the brain. , 1985, AJR. American journal of roentgenology.

[22]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[23]  J. Fries,et al.  A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. , 1982, Arthritis and rheumatism.

[24]  M. Lockshin,et al.  Central nervous system lupus erythematosus. The need for classification. , 1979, Arthritis and rheumatism.

[25]  A. Claudy,et al.  Disease activity in systemic lupus erythematosus , 1979, Clinical and experimental dermatology.

[26]  L. Kagen,et al.  Central Nervous System Lupus Erythematosus , 1979 .

[27]  S. Ohman,et al.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.

[28]  M. Urowitz,et al.  Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. , 1977, The Quarterly journal of medicine.

[29]  F. Arnett,et al.  NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS, CLINICAL SPECTRUM, AND RELATIONSHIP TO OTHER FEATURES OF THE DISEASE , 1976, Medicine.

[30]  T. Gibson,et al.  Nervous system involvement in systemic lupus erythematosus , 1976, Annals of the rheumatic diseases.

[31]  Benjamin A Lipsky,et al.  Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. , 1975, The American journal of medicine.

[32]  P. Cheah,et al.  Mortality in Systemic Lupus Erythematosus: A 10-Year Review , 1973, British medical journal.

[33]  D. Estes,et al.  THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS , 1971, Medicine.